Furthermore, while the downregulation of KRAS has been shown to modulate spheroid formation [54], this demonstration of enhanced efficacy of KRAS modulation in 3D morphology is also novel and highlights the importance of studying cancers in an array of morphologies and particularly, in those closer to physiological relevance for patients. This evidence concerns the gene KRAS and cancer.